Predicting the Risk of Any, Metastatic, and Fatal Prostate Cancer Using a Polygenic Hazard Score
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Polygenic risk of any, metastatic, and fatal prostate cancer in the Million Veteran Program
J. Natl. Cancer Inst 2022 Oct 28;[EPub Ahead of Print], MS Pagadala, J Lynch, R Karunamuni, PR Alba, KM Lee, FY Agiri, T Anglin, H Carter, JM Gaziano, GK Jasuja, R Deka, BS Rose, MS Panizzon, RL Hauger, TM SeibertFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.